Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 251

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Radiation Segmentectomy: Potential Curative Therapy for Early Hepatocellular Carcinoma

Lewandowski, Robert J., Gabr, Ahmed, Abouchaleh, Nadine, Ali, Rehan, Al Asadi, Ali, Mora, Ronald A., Kulik, Laura, Ganger, Daniel, Desai, Kush, Thornburg, Bartley, Mouli, Samdeep, Hickey, Ryan, Caicedo, Juan Carlos, Abecassis, Michael, Riaz, Ahsun, Salem, Riad · 2018 · Radiology

Abstract

Purpose To report long-term outcomes of radiation segmentectomy (RS) for early hepatocellular carcinoma (HCC). The authors hypothesized that outcomes are comparable to curative treatments for patients with solitary HCC less than or equal to 5 cm and preserved liver function. Materials and Methods This retrospective study included 70 patients (median age, 71 years; range, 22–96 years) with solitary HCC less than or equal to 5 cm not amenable to percutaneous ablation who underwent RS (dose of >190 Gy) between 2003 and 2016. Patients who underwent subsequent curative liver transplantation were excluded to eliminate this confounding variable affecting survival. Radiologic response of time to progression and median overall survival were estimated by using the Kaplan-Meier method per the guidelines of the European Association for the Study of the Liver (EASL) and the World Health Organization (WHO). Results Seventy patients were treated with RS over 14 years. Sixty-three patients (90%) showed response by using EASL criteria, of which 41 (59%) showed complete response. Fifty patients (71%) achieved response by using WHO criteria, of which 11 (16%) achieved complete response. Response rates at 6 months were 86% and 49% by using EASL and WHO criteria, respectively. Median time to progression was 2.4 years (95% confidence interval: 2.1, 5.7), with 72% of patients having no target lesion progression at 5 years. Median overall survival was 6.7 years (95% confidence interval: 3.1, 6.7); survival probability at 1, 3, and 5 years was 98%, 66%, and 57%, respectively. Overall survival probability at 1, 3, and 5 years was 100%, 82%, and 75%, respectively, in patients with baseline tumor size less than or equal to 3 cm (n = 45) and was significantly longer than in patients with tumors greater than 3 cm (P = .026). Conclusion RS provides response rates, tumor control, and survival outcomes comparable to curative-intent treatments for selected patients with early-stage HCC who have preserved liver function. © RSNA, 2018 Online supplemental material is available for this article.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1148/radiol.2018171768

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 251

Metadata

Authors
Lewandowski, R. J., Gabr, A., Abouchaleh, N., Ali, R., Al Asadi, A., Mora, R. A., Kulik, L., Ganger, D., Desai, K., Thornburg, B., Mouli, S., Hickey, R., Caicedo, J. C., Abecassis, M., Riaz, A., & Salem, R.
Venue
Radiology
Published
2018-06
Volume
287
Issue
3
Pages
1050-1058
ISSN
  • 0033-8419 (ISSN-L)
  • 1527-1315
OpenAlex
W2802010540
Cited by
251
References
2
FWCI
13.47
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Radiation Segmentectomy: Potential Curative Therapy for Early Hepatocellular Carcinoma. https://app.cochat.ai/papers/10.1148/radiol.2018171768
The paper
Lewandowski, R. J., Gabr, A., Abouchaleh, N., Ali, R., Al Asadi, A., Mora, R. A., Kulik, L., Ganger, D., Desai, K., Thornburg, B., Mouli, S., Hickey, R., Caicedo, J. C., Abecassis, M., Riaz, A., & Salem, R. (2018). Radiation Segmentectomy: Potential Curative Therapy for Early Hepatocellular Carcinoma. Radiology. https://doi.org/10.1148/radiol.2018171768

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.